Ladyboon Tablet contains Dydrogesterone 10 mg, a synthetic progestogen used primarily in the management of various gynecological conditions related to progesterone deficiency. It is indicated for the treatment of menstrual disorders such as irregular menstruation, secondary amenorrhea, and dysfunctional uterine bleeding. Additionally, Ladyboon is employed in supporting luteal phase insufficiency during assisted reproductive techniques and in the prevention of threatened miscarriage in early pregnancy. Dydrogesterone acts by mimicking the natural hormone progesterone, thereby regulating the menstrual cycle and maintaining the endometrial lining. The drug is well-absorbed orally and has a favorable safety profile with minimal androgenic, estrogenic, or glucocorticoid effects. Dosage and duration of treatment should be individualized based on the clinical condition and physician’s discretion. Common adverse effects are generally mild and may include headache, breast tenderness, and gastrointestinal discomfort. Ladyboon Tablet is contraindicated in patients with known hypersensitivity to dydrogesterone or any component of the formulation, active thromboembolic disorders, or hormone-sensitive malignancies. It is essential to use this medication under medical supervision to ensure appropriate monitoring and to optimize therapeutic outcomes.